checkAd
    Startseite > Aktien > LivaNova > Nachrichten
    LivaNova Aktie
    48,40
     
    EUR
    -12,40 %
    -6,85 EUR
    Letzter Kurs 06.06.24 Lang & Schwarz
    47,80
     
    EUR
    149 STK
    Geldkurs 06.06.24
    49,00
     
    EUR
    149 STK
    Briefkurs 06.06.24
    ISIN: GB00BYMT0J19 · WKN: A14156 · Großbritannien

    Neueste Nachrichten

    LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
    06.06.24 · Business Wire (engl.) · LivaNova
    LivaNova to Present at the Goldman Sachs Healthcare Conference
    23.05.24 · Business Wire (engl.) · LivaNova
    LivaNova Reports First-Quarter 2024 Results
    01.05.24 · Business Wire (engl.) · LivaNova
    LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
    30.04.24 · Business Wire (engl.) · LivaNova
    LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
    25.04.24 · Business Wire (engl.) · LivaNova
    LivaNova to Announce First-Quarter 2024 Results
    21.03.24 · Business Wire (engl.) · LivaNova
    LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
    20.03.24 · Business Wire (engl.) · LivaNova
    LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
    06.03.24 · Business Wire (engl.) · LivaNova
    LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
    04.03.24 · Business Wire (engl.) · LivaNova
    LivaNova to Present at the Barclays Global Healthcare Conference
    04.03.24 · Business Wire (engl.) · LivaNova
    LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
    21.02.24 · Business Wire (engl.) · LivaNova
    LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
    05.02.24 · Business Wire (engl.) · LivaNova